All Stories

  1. Predicting IPF outcomes: lung function evaluation by %predicted and z-score

    Article • September 2021, European Respiratory Society (ERS)

    Piotr Boros

  2. Inhaled therapies in patients with moderate COPD in clinical practice: current thinking

    Article • International Journal of Chronic Obstructive Pulmonary Disease, December 2017, Dove Medical Press

    Piotr Boros, Professor attila somfay, Ruzena Tkacova, Professor Arschang Valipour, MD MHA Amnon Philip Ariel, MD Vladimir Koblizek

  3. Systemic treatment for sarcoidosis was needed for 16% of 1810 Caucasian patients

    Article • The Clinical Respiratory Journal, August 2017, Wiley

    Piotr Boros, Magdalena Martusewicz-Boros

  4. Risk factors for cardiac involvement in sarcoidosis - A case-control study in 201 Caucasian patients

    Article • September 2016, European Respiratory Society (ERS)

    Piotr Boros

  5. Prevalence of cardiac sarcoidosis in white population

    Article • Medicine, August 2016, Wolters Kluwer Health

    Piotr Boros

  6. Use the Lower Limit of Normal, Not 80% Predicted, in Judging Eligibility for Lung Resection

    Article • Respiration, January 2016, Karger Publishers

    Piotr Boros

  7. Cardiac Sarcoidosis: Is it More Common in Men?

    Article • Lung, September 2015, Springer Science + Business Media

    Piotr Boros

  8. Polish Respiratory Society guidelines for the methodology and interpretation of the 6 minute walk test (6MWT)

    Article • Pneumonologia i Alergologia Polska, July 2015, VM Media SP. zo.o VM Group SK

    Piotr Boros

  9. Chronic obstructive pulmonary disease in Poland: distribution of patients according to the new GOLD 2011 classification. Cross-sectional survey

    Article • Pneumonologia i Alergologia Polska, October 2014, VM Media SP. zo.o VM Group SK

    Piotr Boros

  10. Respiratory system involvement in chronic liver diseases

    Article • Polish Archives of Internal Medicine, November 2013, Towarzystwo Internistow Polskich/Polish Society of Internal Medicine

    Piotr Boros

  11. Measurement of FEF25-75% and FEF75% does not contribute to clinical decision making

    Article • European Respiratory Journal, September 2013, European Respiratory Society (ERS)

    Piotr Boros, Danny Brazzale

  12. Grading the severity of airways obstruction: new wine in new bottles

    Article • European Respiratory Journal, August 2013, European Respiratory Society (ERS)

    Piotr Boros, Danny Brazzale

  13. Implications of adopting the Global Lungs Initiative 2012 all-age reference equations for spirometry

    Article • European Respiratory Journal, March 2013, European Respiratory Society (ERS)

    Piotr Boros, Danny Brazzale

  14. Reversibility of Airway Obstruction vs Bronchodilatation: Do We Speak the Same Language?

    Article • COPD Journal of Chronic Obstructive Pulmonary Disease, April 2012, Taylor & Francis

    Piotr Boros

  15. Health state and the quality of life in patients with chronic obstructive pulmonary disease in Poland. A study using the EQ‑5D questionnaire

    Article • Polish Archives of Internal Medicine, February 2012, Towarzystwo Internistow Polskich/Polish Society of Internal Medicine

    Piotr Boros

  16. Why Put Patients With Sarcoidosis In A Body Box?

    Article • May 2011, American Thoracic Society

    Piotr Boros

  17. Impaired lung compliance and DL,CO but no restrictive ventilatory defect in sarcoidosis

    Article • European Respiratory Journal, April 2010, European Respiratory Society (ERS)

    Piotr Boros

  18. Value of Spirometry in Detecting Volume Restriction in Interstitial Lung Disease Patients

    Article • Respiration, August 2004, Karger Publishers

    Piotr Boros